British Journal of Cancer
-
Publication Venue For
- Effect of aerobic training on the host systemic milieu in patients with solid tumours: An exploratory correlative study. 112:825-831. 2015
- Erratum: Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium (British Journal of Cancer (2009) 100 (412-420) DOI: 10.1038/sj.bjc.6604820 www.bjcancer.com). 101:1805. 2009
- In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs (British Journal of Cancer (2008) 99, (294-304) DOI: 10.1038/sj.bjc.6604459). 100:1012. 2009
- Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. 100:412-420. 2009
- Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis.. 98:294-299. 2008
- Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis.. 98:282-288. 2008
- Treatment with imatinib improves drug delivery and efficacy in NSCLC xenografts.. 97:735-740. 2007
- Regulation of mammalian horizontal gene transfer by apoptotic DNA fragmentation.. 95:1696-1700. 2006
- Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-beta and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation.. 95:1013-1019. 2006
- HIF-1 and tumour radiosensitivity.. 95:1-5. 2006
- Birth weight and breast cancer risk.. 94:1734-1737. 2006
- Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis.. 93:1350-1355. 2005
- Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York.. 93:699-708. 2005
- Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer.. 93:195-199. 2005
- Characterisation of systemic dissemination of nonreplicating adenoviral vectors from tumours in local gene delivery.. 92:1414-1420. 2005
- The role of dendritic cell precursors in tumour vasculogenesis.. 92:1182-1187. 2005
- Targeted radiotherapy of brain tumours.. 90:1469-1473. 2004
- Invasion and MMP expression profile in desmoid tumours.. 90:1443-1449. 2004
- Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci.. 90:510-514. 2004
- Surrogate markers in antiangiogenesis clinical trials.. 89:8-14. 2003
- Glutathione S-transferase M1 and T1 genetic polymorphisms, alcohol consumption and breast cancer risk.. 88:58-62. 2003
- Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix.. 86:274-281. 2002
- Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour).. 85:98-101. 2001
- Transfection of the sodium iodide symporter gene for tumour targeting with radioiodine and [At-211]radioastatine. 85:24-24. 2001
- Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists.. 83:906-913. 2000
- A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse.. 83:588-593. 2000
- Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer.. 83:324-328. 2000
- Vascular permeability in a human tumour xenograft: molecular charge dependence.. 82:1513-1518. 2000
- Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features.. 82:1191-1197. 2000
- Lack of evidence for MHC-unrestricted (atypical) recognition of mucin by mucinous pancreatic tumour-reactive T-cells.. 82:691-701. 2000
- Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522.. 81:1274-1279. 1999
- Targeted cytotoxic analogue of bombesin/gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice.. 81:966-971. 1999
- Laminin mediates tethering and spreading of colon cancer cells in physiological shear flow.. 80:1927-1934. 1999
- Bcl10 is not a target for frequent mutation in human carcinomas.. 80:1575-1576. 1999
- G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder.. 80:1175-1184. 1999
- Quantification of longitudinal tissue pO2 gradients in window chamber tumours: impact on tumour hypoxia.. 79:1717-1722. 1999
- Swainsonine protects both murine and human haematopoietic systems from chemotherapeutic toxicity.. 80:87-95. 1999
- The effects of hyperoxic and hypercarbic gases on tumour blood flow.. 80:117-126. 1999
- Progesterone receptor gene polymorphism and risk for breast and ovarian cancer.. 78:277. 1998
- Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions.. 77:2061-2068. 1998
- Cytotoxicity of alpha-particle-emitting astatine-211-labelled antibody in tumour spheroids: no effect of hyperthermia.. 77:753-759. 1998
- Combretastatin A-4 P as a tumour vascular targeting agent. 78:48-48. 1998
- Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis.. 77:51-56. 1998
- 3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells. 76:226-233. 1997
- 3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.. 76:226-233. 1997
- Effects of diethylamine/nitric oxide on blood perfusion and oxygenation in the R3230Ac mammary carcinoma.. 76:429-437. 1997
- Fluorescence ratio imaging of interstitial pH in solid tumours: effect of glucose on spatial and temporal gradients.. 74:1206-1215. 1996
- Localisation of [131I]MIBG in nude mice bearing SK-N-SH human neuroblastoma xenografts: effect of specific activity.. 73:1171-1177. 1996
- Arteriolar oxygenation in tumour and subcutaneous arterioles: Effects of inspired air oxygen content. 74. 1996
- Microvascular studies on the origins of perfusion-limited hypoxia. 74. 1996
- The mechanisms by which hyperbaric oxygen and carbogen improve tumour oxygenation.. 72:1120-1124. 1995
- New MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment.. 72:250. 1995
- Flunarizine enhancement of melphalan activity against drug-sensitive/resistant rhabdomyosarcoma.. 71:1181-1187. 1995
- Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma.. 71:1169-1174. 1995
- Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma. 71:1169-1174. 1995
- Differences in leucocyte-endothelium interactions between normal and adenocarcinoma bearing tissues in response to radiation.. 69:883-889. 1994
- The effect of flunarizine on erythrocyte suspension viscosity under conditions of extreme hypoxia, low pH, and lactate treatment.. 67:734-741. 1993
- 2'-deoxy-5-azacytidine increases binding of cisplatin to DNA by a mechanism independent of DNA hypomethylation.. 67:209-215. 1993
- Genetic susceptibility to naevi--a twin study.. 64:1164-1167. 1991
- Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitis.. 62:637-642. 1990
- Flow cytometric analysis of cell surface carbohydrates in metastatic human breast cancer.. 62:238-242. 1990
- Double antibody radioimmunoassay for monitoring metastatic breast cancer.. 58:362-367. 1988
- B-lymphocytes from melanoma patients and normal individuals react with melanoma cells but also with irrelevant antigens.. 58:182-185. 1988
- Influence of tumour size on human prostate tumour metastasis in athymic nude mice.. 51:419-423. 1985
- A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.. 51:283-289. 1985
- C-type virus particles in human urogenital tumours after heterotransplantation into nude mice.. 39:35-42. 1979
- Inducers of Friend leukaemic cell differentiation in vitro--effects of in vivo administration.. 33:634-645. 1976
- Proceedings: Oral and pharyngeal cancers in textile workers.. 32:249. 1975
- Refusal in testicular cancer patients: implications for surveillance.. 65:786. 1992
- Enhancement of targeted radiotehrapy in neuroblastoma: A novel gene therapy approach 2004
- Targeted radiotherapy of brain tumours 2003
- Targets of the ABL tyrosine kinases in normal and transformed cells. 1998